Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 9, 2008, Pages 1419-1425

  Shi, Jun Ping ^a,b   Fan, Jian Gao ^a,c   Wu, Rui ^b   Gao, Xiao Qian ^b   Zhang, Li ^b   Wang, Hao ^b   Farrell, Geoffrey C ^c  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b Hangzhou Sixth People's Hospital   (China)

^c The Australian National University   (Australia)

Author keywords

Chronic hepatitis B; Liver fibrosis; Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HEPATITIS B(E) ANTIGEN; TRIACYLGLYCEROL; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHILD; CHINESE; CHRONIC HEPATITIS; DISEASE SEVERITY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VIRUS LOAD;

EID: 49849087685     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05531.x     Document Type: Article

References (39)

1. Williams R. Global challenges in liver disease. Hepatology 2006 44 : 521 6.
2. Amarapurkar DN, Hashimoto E, Lesmana LA et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J. Gastroenterol. Hepatol. 2007 22 : 788 93.
3. Larter CZ, Farrell GC. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006 43 (Suppl. 1 S99 S112.
4. Farrell GC, Chitturi S, Lau GKK et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary. J. Gastroenterol. Hepatol. 2007 22 : 775 7.
5. Fan JG, Zhu J, Li XJ et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 2005 43 : 508 14.
6. Chitturi S, Farrell GC, Hashimoto E et al. Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposal guidelines. J. Gastroenterol. Hepatol. 2007 22 : 778 87.
7. Fan JG, Saibara T, Chitturi S et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J. Gastroenterol. Hepatol. 2007 22 : 794 80.
8. Sanyal AJ, Contos MJ, Sterling RK et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am. J. Gastroenterol. 2003 98 : 2064 71.
9. Cua IHY, Hui JM, Bandara P et al. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology 2007 46 : 66 73.
10. Mohammad Alizadeh AH, Fallahian F, Alavian SM et al. Insulin resistance in chronic hepatitis B and C. Indian J. Gastroenterol. 2006 25 : 286 9.
11. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J. Hepatol. 2005 43 : 38 44.
12. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 1991 13 : 372 4.
13. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999 94 : 2467 72.
14. Anuurad E, Shiwaku K, Nogi A et al. The new BMI criteria for Asians by the regional office for the western Pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J. Occup. Health 2003 45 : 335 43.
15. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003 289 : 2560 72.
16. Gu D, Reynold K, Wu X et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005 365 : 1398 405.
17. Shaw JE, de Courten M, Boyko EJ, Zimmet PZ. Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care 1999 22 : 762 6.
18. Fan JG, Li L, Cai XB et al. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J. Gastroenterol. Hepatol. 2007 22 : 663 8.
19. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for non-alcoholic fatty liver diseases. Hepatology 2005 41 : 1313 21.
20. Thomopoulos KC, Arvaniti V, Tsamantas AC et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur. J. Gastroenterol. Hepatol. 2006 18 : 233 7.
21. Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993 105 : 1824 32.
22. Bondini S, Kallman J, Wheeler A et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007 27 : 607 11.
23. Altiparmak E, Koklu S, Yalinkilic M et al. Viral and host causes of fatty liver in chronic hepatitis B. World J. Gastroenterol. 2005 11 : 3056 9.
24. Tsochatzis E, Papatheodoridis GV, Manesis EK. Hepatic steatosis in chronic hepatitis B develop due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Dig. Liver Dis. 2007 39 : 936 42.
25. Malhotra V, Sakhuja P, Gondal R et al. Histological comparison of chronic hepatitis B and C in an Indian population. Trop. Gastroenterol. 2000 21 : 20 1.
26. Lefkowitch JH, Schiff ER, Davis GL et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993 104 : 595 603.
27. Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine 1962 41 : 249 76.
28. Naveau S, Giraud V, Borotto E et al. Excess weight risk factor for alcoholic liver disease. Hepatology 1997 25 : 108 11.
29. Kim KH, Shin HJ, Kim K et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPAR gamma. Gastroenterology 2007 132 : 1955 67.
30. Bedogni G, Miglioli L, Masutti F et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005 42 : 44 52.
31. Cindoruk M, Karakan T, Unal S. Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection. J. Clin. Gastroenterol. 2007 41 : 513 17.
32. Wang CC, Hsu CS, Liu CJ et al. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J. Gastroenterol. Hepatol. 2008 23 : 779 82.
33. Fan JG, Chitturi S Hepatitis B and fatty liver: causal or coincidental? J. Gastroenterol. Hepatol. 2008 23 : 679 82.
34. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin. Chim. Acta 2007 380 : 238 40.
35. Jan CF, Chen CJ, Chiu YH et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int. J. Obes. (Lond) 2006 30 : 794 9.
36. Chu CM, Lin DY, Liaw YF. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? Int. J. Obes. 2007 31 : 871 5.
37. Demir K, Akyuz F, Ozdil S et al. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis. Ann. Hepatol. 2007 6 : 96 102.
38. Bjornsson E, Angulo P. Hepatitis C and steatosis. Arch. Med. Res. 2007 38 : 621 7.
39. Fan JG. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. J. Dig. Dis. 2008 9 : 63 7.